The 2017 Conference has the following exciting Topic Highlights:
• Evolving HBV therapy - combination and stopping NA
• Future treatments for HBV
• HCC debate: East vs West
• DAA difficult to treat cases
• DAA treatment failures and resistance
• HCC immunotherapy
• Fatty liver disease in Asia
• Therapeutic advances in NASH
CATEGORY
REGISTRATION FEES in USD
Delegate (Medical Doctor/Scientist)*
o 150
Trainee/Student/Nurse*
o 100
Generated by meetings and positions 5.0 by Kai Garlipp WWW: Kai Garlipp, Frank S. Zollmann. 7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.